BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 32733086)

  • 21. Early detection of breast cancer: new biomarker tests on the horizon?
    Jotwani AC; Gralow JR
    Mol Diagn Ther; 2009 Dec; 13(6):349-57. PubMed ID: 19925032
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical outcomes of mammography in the National Breast and Cervical Cancer Early Detection Program, 2009-2012.
    White A; Miller J; Royalty J; Ryerson AB; Benard V; Helsel W; Kammerer W
    Cancer Causes Control; 2015 May; 26(5):723-32. PubMed ID: 25809209
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Blinded double reading yields a higher programme sensitivity than non-blinded double reading at digital screening mammography: a prospected population based study in the south of The Netherlands.
    Klompenhouwer EG; Voogd AC; den Heeten GJ; Strobbe LJ; de Haan AF; Wauters CA; Broeders MJ; Duijm LE
    Eur J Cancer; 2015 Feb; 51(3):391-9. PubMed ID: 25573788
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Benefits, harms, and cost-effectiveness of supplemental ultrasonography screening for women with dense breasts.
    Sprague BL; Stout NK; Schechter C; van Ravesteyn NT; Cevik M; Alagoz O; Lee CI; van den Broek JJ; Miglioretti DL; Mandelblatt JS; de Koning HJ; Kerlikowske K; Lehman CD; Tosteson AN
    Ann Intern Med; 2015 Feb; 162(3):157-66. PubMed ID: 25486550
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Segregation of ovarian cancer stage exploiting spectral biomarkers derived from blood plasma or serum analysis: ATR-FTIR spectroscopy coupled with variable selection methods.
    Lima KM; Gajjar KB; Martin-Hirsch PL; Martin FL
    Biotechnol Prog; 2015; 31(3):832-9. PubMed ID: 25832726
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Breast cancer screening: On our way to the future].
    Delaloge S; Bachelot T; Bidard FC; Espie M; Brain E; Bonnefoi H; Gligorov J; Dalenc F; Hardy-Bessard AC; Azria D; Jacquin JP; Lemonnier J; Jacot W; Goncalves A; Coutant C; Ganem G; Petit T; Penault-Llorca F; Debled M; Campone M; Levy C; Coudert B; Lortholary A; Venat-Bouvet L; Grenier J; Bourgeois H; Asselain B; Arvis J; Castro M; Tardivon A; Cox DG; Arveux P; Balleyguier C; André F; Rouzier R;
    Bull Cancer; 2016 Sep; 103(9):753-63. PubMed ID: 27473920
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Five Consecutive Years of Screening with Digital Breast Tomosynthesis: Outcomes by Screening Year and Round.
    Conant EF; Zuckerman SP; McDonald ES; Weinstein SP; Korhonen KE; Birnbaum JA; Tobey JD; Schnall MD; Hubbard RA
    Radiology; 2020 May; 295(2):285-293. PubMed ID: 32154771
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Screening MRI in Women With a Personal History of Breast Cancer.
    Lehman CD; Lee JM; DeMartini WB; Hippe DS; Rendi MH; Kalish G; Porter P; Gralow J; Partridge SC
    J Natl Cancer Inst; 2016 Mar; 108(3):. PubMed ID: 26744477
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Potential of Liquid Biopsies for Breast Cancer Screening, Diagnosis, and Response to Treatment.
    Eigeliene N; Saarenheimo J; Jekunen A
    Oncology; 2019; 96(3):115-124. PubMed ID: 30654364
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Supplemental Screening for Breast Cancer in Women With Dense Breasts: A Systematic Review for the U.S. Preventive Services Task Force.
    Melnikow J; Fenton JJ; Whitlock EP; Miglioretti DL; Weyrich MS; Thompson JH; Shah K
    Ann Intern Med; 2016 Feb; 164(4):268-78. PubMed ID: 26757021
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dutch digital breast cancer screening: implications for breast cancer care.
    Timmers JM; den Heeten GJ; Adang EM; Otten JD; Verbeek AL; Broeders MJ
    Eur J Public Health; 2012 Dec; 22(6):925-9. PubMed ID: 22158996
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnostic segregation of human breast tumours using Fourier-transform infrared spectroscopy coupled with multivariate analysis: Classifying cancer subtypes.
    Luo Y; Liu H; Wu C; Paraskevaidi M; Deng Y; Shi W; Yuan Y; Feng R; Martin FL; Pang W
    Spectrochim Acta A Mol Biomol Spectrosc; 2021 Jul; 255():119694. PubMed ID: 33799187
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Using medical imaging for a comprehensive breast cancer screening program].
    Dilhuydy MH
    Bull Cancer; 2009 Nov; 96(11):1071-86. PubMed ID: 19887333
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Investigation of the influence of high-risk human papillomavirus on the biochemical composition of cervical cancer cells using vibrational spectroscopy.
    Ostrowska KM; Malkin A; Meade A; O'Leary J; Martin C; Spillane C; Byrne HJ; Lyng FM
    Analyst; 2010 Dec; 135(12):3087-93. PubMed ID: 20967345
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Determination of Salivary Sialic Acid Through Nanotechnology: A Useful Biomarker for the Screening of Breast Cancer.
    Hernández-Arteaga AC; de Jesús Zermeño-Nava J; Martínez-Martínez MU; Hernández-Cedillo A; Ojeda-Galván HJ; José-Yacamán M; Navarro-Contreras HR
    Arch Med Res; 2019 Apr; 50(3):105-110. PubMed ID: 31495386
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Breast MRI screening for average-risk women: A monte carlo simulation cost-benefit analysis.
    Mango VL; Goel A; Mema E; Kwak E; Ha R
    J Magn Reson Imaging; 2019 Jun; 49(7):e216-e221. PubMed ID: 30632645
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessing breast cancer risk within the general screening population: developing a breast cancer risk model to identify higher risk women at mammographic screening.
    Abdolell M; Payne JI; Caines J; Tsuruda K; Barnes PJ; Talbot PJ; Tong O; Brown P; Rivers-Bowerman M; Iles S
    Eur Radiol; 2020 Oct; 30(10):5417-5426. PubMed ID: 32358648
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ultrasound as an Adjunct to Mammography for Breast Cancer Screening: A Health Technology Assessment.
    Health Quality Ontario
    Ont Health Technol Assess Ser; 2016; 16(15):1-71. PubMed ID: 27468326
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The added value of mammography in different age-groups of women with and without BRCA mutation screened with breast MRI.
    Vreemann S; van Zelst JCM; Schlooz-Vries M; Bult P; Hoogerbrugge N; Karssemeijer N; Gubern-Mérida A; Mann RM
    Breast Cancer Res; 2018 Aug; 20(1):84. PubMed ID: 30075794
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quantification of Lipid Phase Order of In Vivo Human Skin Using Attenuated Total Reflection Fourier Transform Infrared (ATR FT-IR) Spectroscopy and Multivariate Curve Resolution Analysis.
    Yarovoy Y; Drutis DM; Hancewicz TM; Garczarek U; Ananthapadmanabhan KP; Misra M
    Appl Spectrosc; 2019 Feb; 73(2):182-194. PubMed ID: 30353745
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.